XOMAP FY 2022 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-84.2% YoY

Gross Profit

$6M95.5% margin

Operating Income

-$17M-288.9% margin

Net Income

-$17M-283.8% margin

EPS (Diluted)

$-1.98

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$28M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$140M

Total Liabilities

$16M

Stockholders' Equity

$124M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$38M	-84.2%
Gross Profit	$6M	$38M	-84.9%
Operating Income	-$17M	$18M	-199.3%
Net Income	-$17M	$16M	-208.3%